Additionally, they were not taking medications that could affect glucose metabolism
Like all medications, GLP-1s can have side effects, especially early in the treatment process
Medicine is moving toward: Pathway-specific modulation Personalized metabolic interventions Regenerative tissue strategies Biomarker-driven monitoring Peptides, due to their structural specificity and receptor selectivity, fit naturally within this emerging framework
10.3389/fphar.2021.748867 101 LinX.XiaoZ.ChenT.LiangS
FIGURE 1 TABLE 1 Physical characteristics, echocardiographic, surface ECG and electrophysiological parameters, and serum marker levels of STD, STD + LCA, HFD and HFD + LCA mice